These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37703322)

  • 1. Development of Potent and Selective Coactivator-Associated Arginine Methyltransferase 1 (CARM1) Degraders.
    Xie H; Bacabac MS; Ma M; Kim EJ; Wang Y; Wu W; Li L; Xu W; Tang W
    J Med Chem; 2023 Sep; 66(18):13028-13042. PubMed ID: 37703322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification, Synthesis, and Biological Evaluations of Potent Inhibitors Targeting Type I Protein Arginine Methyltransferases.
    Li X; Zhang L; Xu J; Liu C; Zhang X; Abdelmoneim AA; Zhang Q; Ke J; Zhang Y; Wang L; Yang F; Luo C; Jin J; Ye F
    J Chem Inf Model; 2022 Feb; 62(3):692-702. PubMed ID: 35098713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based discovery of potent CARM1 inhibitors for colorectal cancer therapy.
    Liu C; Li Y; Liu Z; Cao C; Lin M; Chen X; Yuan M; Fan Y; Gu X; Wang L; Yang F; Ye F; Jin J
    Eur J Med Chem; 2024 Apr; 269():116288. PubMed ID: 38460270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automethylation of CARM1 allows coupling of transcription and mRNA splicing.
    Kuhn P; Chumanov R; Wang Y; Ge Y; Burgess RR; Xu W
    Nucleic Acids Res; 2011 Apr; 39(7):2717-26. PubMed ID: 21138967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone arginine methyltransferase CARM1 selective inhibitor TP-064 induces apoptosis in endometrial cancer.
    Inoue F; Sone K; Toyohara Y; Tanimoto S; Takahashi Y; Kusakabe M; Kukita A; Honjoh H; Nishijima A; Taguchi A; Miyamoto Y; Tanikawa M; Iriyama T; Uchino MM; Tsuruga T; Wada-Hiraike O; Oda K; Osuga Y
    Biochem Biophys Res Commun; 2022 Apr; 601():123-128. PubMed ID: 35245741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential CARM1 expression in prostate and colorectal cancers.
    Kim YR; Lee BK; Park RY; Nguyen NT; Bae JA; Kwon DD; Jung C
    BMC Cancer; 2010 May; 10():197. PubMed ID: 20462455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A hypermethylation strategy utilized by enhancer-bound CARM1 to promote estrogen receptor α-dependent transcriptional activation and breast carcinogenesis.
    Peng BL; Li WJ; Ding JC; He YH; Ran T; Xie BL; Wang ZR; Shen HF; Xiao RQ; Gao WW; Ye TY; Gao X; Liu W
    Theranostics; 2020; 10(8):3451-3473. PubMed ID: 32206101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unraveling the complexity of histone-arginine methyltransferase CARM1 in cancer: From underlying mechanisms to targeted therapeutics.
    Jin W; Zhang J; Chen X; Yin S; Yu H; Gao F; Yao D
    Biochim Biophys Acta Rev Cancer; 2023 Jul; 1878(4):188916. PubMed ID: 37196782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coactivator-associated arginine methyltransferase-1 enhances nuclear factor-kappaB-mediated gene transcription through methylation of histone H3 at arginine 17.
    Miao F; Li S; Chavez V; Lanting L; Natarajan R
    Mol Endocrinol; 2006 Jul; 20(7):1562-73. PubMed ID: 16497732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of small molecule ligands for the von Hippel-Lindau (VHL) E3 ligase and their use as inhibitors and PROTAC degraders.
    Diehl CJ; Ciulli A
    Chem Soc Rev; 2022 Oct; 51(19):8216-8257. PubMed ID: 35983982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CARM1 arginine methyltransferase as a therapeutic target for cancer.
    Santos M; Hwang JW; Bedford MT
    J Biol Chem; 2023 Sep; 299(9):105124. PubMed ID: 37536629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virtual Screening with a Structure-Based Pharmacophore Model to Identify Small-Molecule Inhibitors of CARM1.
    Ran T; Li W; Peng B; Xie B; Lu T; Lu S; Liu W
    J Chem Inf Model; 2019 Jan; 59(1):522-534. PubMed ID: 30607947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of Highly Potent and Efficient PROTAC Degraders of Androgen Receptor (AR) by Employing Weak Binding Affinity VHL E3 Ligase Ligands.
    Han X; Zhao L; Xiang W; Qin C; Miao B; Xu T; Wang M; Yang CY; Chinnaswamy K; Stuckey J; Wang S
    J Med Chem; 2019 Dec; 62(24):11218-11231. PubMed ID: 31804827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transition state mimics are valuable mechanistic probes for structural studies with the arginine methyltransferase CARM1.
    van Haren MJ; Marechal N; Troffer-Charlier N; Cianciulli A; Sbardella G; Cavarelli J; Martin NI
    Proc Natl Acad Sci U S A; 2017 Apr; 114(14):3625-3630. PubMed ID: 28330993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-Stage Strategy for Development of Proteolysis Targeting Chimeras and its Application for Estrogen Receptor Degraders.
    Roberts BL; Ma ZX; Gao A; Leisten ED; Yin D; Xu W; Tang W
    ACS Chem Biol; 2020 Jun; 15(6):1487-1496. PubMed ID: 32255606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coactivator-associated arginine methyltransferase 1 controls oligodendrocyte differentiation in the corpus callosum during early brain development.
    Ishino Y; Shimizu S; Tohyama M; Miyata S
    Dev Neurobiol; 2022 Apr; 82(3):245-260. PubMed ID: 35220691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The coactivator-associated arginine methyltransferase is necessary for muscle differentiation: CARM1 coactivates myocyte enhancer factor-2.
    Chen SL; Loffler KA; Chen D; Stallcup MR; Muscat GE
    J Biol Chem; 2002 Feb; 277(6):4324-33. PubMed ID: 11713257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CARM1 (PRMT4) Acts as a Transcriptional Coactivator during Retinoic Acid-Induced Embryonic Stem Cell Differentiation.
    Quintero CM; Laursen KB; Mongan NP; Luo M; Gudas LJ
    J Mol Biol; 2018 Oct; 430(21):4168-4182. PubMed ID: 30153436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CARM1/PRMT4: Making Its Mark beyond Its Function as a Transcriptional Coactivator.
    Suresh S; Huard S; Dubois T
    Trends Cell Biol; 2021 May; 31(5):402-417. PubMed ID: 33485722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Requirement for multiple domains of the protein arginine methyltransferase CARM1 in its transcriptional coactivator function.
    Teyssier C; Chen D; Stallcup MR
    J Biol Chem; 2002 Nov; 277(48):46066-72. PubMed ID: 12351636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.